Refocus Group, Inc. Stock Other OTC
Equities
RFCS
US75865X2027
Biotechnology & Medical Research
Financials (USD)
Sales 2003 | - | Sales 2004 | - | Capitalization | 2.59M |
---|---|---|---|---|---|
Net income 2003 | -5M | Net income 2004 | -3M | EV / Sales 2003 | - |
Net cash position 2003 | 3 | Net Debt 2004 | 0.28 | EV / Sales 2004 | - |
P/E ratio 2003 |
-1.51
x | P/E ratio 2004 |
-0.67
x | Employees | - |
Yield 2003 * |
-
| Yield 2004 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
J. Michael Judy
CEO | Chief Executive Officer | - | 13-10-27 |
David Schanzlin
CTO | Chief Tech/Sci/R&D Officer | - | 12-01-31 |
Selene A. Burke
CTO | Chief Tech/Sci/R&D Officer | - | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 10-12-31 | |
Thomas M. Loarie
CHM | Chairman | - | 13-12-31 |
Thomas Lyles
BRD | Director/Board Member | - | 05-02-28 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |